8-K: Chemung Financial Corporation Secures $45 Million in Subordinated Debt to Bolster Capital and Fuel Strategic Growth

Chemung Financial Corporation has successfully issued $45 million in 7.75% Fixed-to-Floating Rate Subordinated Notes due 2035, aiming to strengthen regulatory capital and support future growth initiatives, including a balance sheet restructuring.

Summary

• Chemung Financial Corporation (CHMG) has entered into Subordinated Note Purchase Agreements to issue $45.0 million in aggregate principal amount of 7.75% Fixed-to-Floating Rate Subordinated Notes due June 15, 2035.
• The notes will bear a fixed annual interest rate of 7.75% until June 15, 2030, payable semi-annually, and then convert to a floating rate equal to Three-Month Term SOFR plus 415 basis points, reset quarterly and payable quarterly.
• Proceeds from the offering are intended for general corporate purposes and to support regulatory capital ratios for growth initiatives, which may include a balance sheet restructuring.
• The company contemplates selling over $200 million of low-yielding available-for-sale (AFS) securities, incurring an estimated pre-tax loss of approximately $17.0 million, with proceeds used to pay down liabilities and fund loan growth.
• The notes are unsecured and subordinated to all senior indebtedness and obligations to general and secured creditors, and are designed to qualify as Tier 2 capital under Federal Reserve Board guidelines.
• Redemption is generally not permitted before the fifth anniversary of the issue date, except upon the occurrence of a Tier 2 Capital Event, Tax Event, or Investment Company Event, and is subject to regulatory approvals.
• The offering was conducted as a private placement, relying on exemptions from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, with resale restrictions applicable.

Sentiment

Score: 8

Explanation: The document outlines a proactive and strategic capital raise combined with a balance sheet optimization plan, projecting significant improvements in profitability and capital ratios. The company demonstrates strong underlying financial health, disciplined credit management, and clear growth initiatives in attractive markets. While there are inherent risks with subordinated debt and a pre-tax loss from asset sales, the overall outlook presented is highly positive and indicative of strong management.

Positives

• The capital raise is expected to enhance the company's capital position, with illustrative pro forma impacts showing an increase in Total Risk Based Capital Ratio by approximately 160 basis points and CET1 Ratio by approximately 30 basis points.
• The contemplated balance sheet restructuring, combined with the debt raise, is projected to significantly improve profitability metrics, including a 17% EPS accretion, a 20 basis point increase in 2025 ROAA to 1.1%, and a 50 basis point increase in 2025 Net Interest Margin to 3.5%.
• The company maintains strong asset quality with Non-Performing Assets to Total Assets at 0.06% and a Texas Ratio of 4.49% as of March 31, 2025, indicating robust credit management.
• Chemung Financial Corporation has a diversified fee income stream, with Wealth Management Revenue accounting for 48.68% of non-interest income, providing a resilient non-interest income stream.
• The company is strategically expanding into higher-growth markets like Buffalo and Albany, leveraging market disruption opportunities from larger bank consolidation, while maintaining dominant market share in its legacy regions.
• The company's operating regions are benefiting from major economic investments, including the Empire AI Consortium, NY SMART I-Corridor Initiative, and the Albany NanoTech Complex, which could drive future growth.

Negatives

• The subordinated notes rank junior in right of payment to senior indebtedness and obligations to general and secured creditors, increasing risk for noteholders in the event of liquidation.
• The contemplated sale of low-yielding AFS securities is expected to result in a pre-tax loss of approximately $17.0 million.
• The company recently paused share repurchases to build up capital levels, which may temporarily reduce shareholder returns through buybacks.
• The interest rate on the notes will convert to a floating rate (Three-Month Term SOFR plus 415 basis points) after June 15, 2030, exposing noteholders to future interest rate fluctuations.

Risks

• **Subordination Risk**: The indebtedness evidenced by the Subordinated Notes is junior in right of payment to Senior Indebtedness, including obligations to general and secured creditors, meaning noteholders would be paid after senior creditors in the event of liquidation.
• **Interest Rate Risk**: After June 15, 2030, the interest rate on the notes will become floating (Three-Month Term SOFR + 415 basis points), exposing noteholders to fluctuations in benchmark rates.
• **Regulatory Approval Risk**: Any redemption of the Subordinated Notes is subject to receipt of required federal and state regulatory approvals or non-objections, including from the Federal Reserve.
• **Economic Conditions and Interest Rates**: Actual results could differ materially from expectations due to changes in economic conditions or interest rates, credit risk, and inflation.
• **Cybersecurity Risks**: The company is exposed to cybersecurity risks, which could materially affect its operations and financial condition.
• **Regulatory Environment Changes**: Changes in law or the regulatory environment, including FDIC assessments and capital adequacy guidelines, could impact the company's financial performance and the treatment of the notes as Tier 2 capital.
• **Competition**: Increased competition in the banking industry could affect the company's ability to grow and maintain profitability.
• **Integration Risk**: Difficulties in managing growth, including potential acquisitions of wealth management firms, whole banks, or branches, could impact performance.
• **Benchmark Transition Risk**: If a Benchmark Transition Event occurs with respect to Three-Month Term SOFR, the Floating Interest Rate will be determined using a Benchmark Replacement, which could affect interest payments.

Future Outlook

Chemung Financial Corporation anticipates that the net proceeds from the subordinated notes offering, combined with a planned balance sheet restructuring involving the sale of low-yielding AFS securities, will significantly enhance its capital position and improve profitability metrics. The company projects a 17% EPS accretion, a 20 basis point increase in 2025 ROAA to 1.1%, and a 50 basis point increase in 2025 Net Interest Margin to 3.5%. These actions are intended to support growth initiatives, particularly in expanding into higher-growth markets like Buffalo and Albany, and to optimize costs through potential branch consolidation and headcount reduction. The company also aims to pursue acquisition opportunities in wealth management firms, whole banks, or branches.

Management Comments

• Management intends to use the net proceeds from the notes for general corporate purposes and to support regulatory capital ratios for growth initiatives, including a balance sheet restructuring.
• The company is focused on dominating legacy markets while actively expanding into higher-growth regions like Buffalo and Albany to ensure a robust deposit base and liquidity.
• Management is committed to maintaining conservative underwriting and solid credit quality, aiming for low non-performing assets and charge-offs.
• The company plans to leverage strong commercial and consumer relationships to drive growth and capitalize on its high-touch relationships with affluent clients for resilient non-interest income.
• Management is actively identifying additional branch consolidation and headcount reduction opportunities to optimize costs and is positioned to acquire wealth management firms, whole banks, or branches under favorable economics.

Industry Context

This debt offering by Chemung Financial Corporation reflects a strategic move common among regional banks to optimize their balance sheets and strengthen capital in a dynamic economic and regulatory environment. The focus on expanding into higher-growth markets like Buffalo and Albany aligns with a broader trend of regional banks seeking to capitalize on economic development initiatives (e.g., Empire AI Consortium, NY SMART I-Corridor Initiative, Albany NanoTech Complex) and market disruption opportunities arising from larger bank consolidation. The emphasis on wealth management growth and cost efficiency also indicates a proactive approach to enhancing profitability and resilience within the competitive financial services industry.

Comparison to Industry Standards

• Chemung Financial Corporation's asset quality metrics, such as Non-Performing Assets to Total Assets (0.06% as of Q1 2025) and Net Charge-offs to Average Loans (0.05% annualized Q1 2025), demonstrate a historically strong and resilient credit performance, comparing favorably to the KBW Regional Bank Index, which has shown higher NPA and NCO percentages in historical periods (e.g., NCOs peaking around 1.2% in 2009 for the index vs. CHMG's consistent low levels).
• The company's Regulatory CRE to Total Risk-Based Capital ratio of 401% (bank level as of 3/31/2025) is being addressed by the capital raise and balance sheet restructuring, with a pro forma target of 360%, indicating a proactive approach to managing concentration risk in line with regulatory guidance for commercial real estate exposure.
• The company's efficiency ratio of 65.6% (Q1 2025) is within the typical range for regional banks, and the planned cost efficiency initiatives aim to further optimize this metric, aligning with industry efforts to improve operational leverage.

Stakeholder Impact

• **Shareholders**: The capital raise and balance sheet restructuring are expected to lead to improved profitability (17% EPS accretion) and stronger capital ratios, potentially increasing shareholder value. However, the recent pause in share repurchases might temporarily impact direct returns from buybacks.
• **Noteholders**: Holders of the new subordinated notes will receive a fixed-to-floating interest rate, but their investment is unsecured and junior to senior indebtedness, exposing them to higher risk in adverse scenarios. Resale restrictions apply due to the private placement.
• **Employees**: The focus on growth initiatives and cost efficiency (including potential headcount reduction) could lead to changes in staffing, though overall business expansion may create new opportunities.
• **Customers**: Enhanced capital and growth initiatives could lead to expanded services, new branch locations, and a stronger financial institution, potentially benefiting customers through improved offerings and stability.
• **Creditors**: Senior creditors benefit from the subordination of these notes, as their claims would be paid in full before any payment on the subordinated notes in the event of liquidation.

Next Steps

• The company intends to use the net proceeds from the notes for general corporate purposes and to support regulatory capital ratios for growth initiatives.
• A balance sheet restructuring is contemplated, involving the sale of low-yielding AFS securities to pay down liabilities and fund loan growth.
• The company will continue its market expansion strategy into higher-growth regions like Buffalo and Albany.
• Ongoing efforts to identify additional branch consolidation and headcount reduction opportunities to optimize costs.
• The company is positioned to acquire wealth management firms, whole banks, or branches under favorable economics.

Key Dates

Recommendation

Keywords

Chemung Financial Corporation, CHMG, Subordinated Notes, Debt Offering, Capital Raise, Tier 2 Capital, Fixed-to-Floating Rate, SOFR, Bank Holding Company, Financial Services, Regional Bank, Balance Sheet Restructuring, Regulatory Capital, Investment, SEC Filing, Form 8-K